St. Jude Medical Receives FDA Clearance for ACross Transseptal Access System (Business Wire via Yahoo! Finance)
ST. PAUL, Minn.----St. Jude Medical, Inc. today announced U.S. Food and Drug Administration clearance and a Health Canada License for the ACross Transseptal Access System, a device that improves control and simplifies the procedure physicians use to access the left atrium during complex cardiac procedures such as atrial fibrillation ablation.

Oncolytics Biotech Inc. Announces 2007 Second Quarter Results (PR Newswire via Yahoo! Finance)
Oncolytics Biotech Inc. today announced its financial results and highlights for the three and six-month periods ended June 30, 2007.

St. Jude Medical Announces FDA Clearance of the Proxis Embolic Protection System (FinanzNachrichten)
St. Jude Medical, ( Nachrichten ) Inc., (NYSE:STJ) today announced U.S. Food and Drug Administration (FDA) clearance of the 7F Proxis Embolic Protection System.